TY - JOUR
T1 - Improved exercise performance and quality of life after percutaneous pulmonary valve implantation
AU - Müller, Jan
AU - Engelhardt, Andrea
AU - Fratz, Sohrab
AU - Eicken, Andreas
AU - Ewert, Peter
AU - Hager, Alfred
PY - 2014/5/15
Y1 - 2014/5/15
N2 - Objective Percutaneous pulmonary valve implantation (PPVI) has emerged as a new approach to treat patients with dysfunctional pulmonary valve conduits. Short- and midterm results have outlined hemodynamic improvements and increase in exercise performance. However, there is a lack of knowledge about quality of life at short term follow-up. Patients and methods From July 2007 to March 2013, we investigated 59 patients (17 female; median age 22.8 years) undergoing PPVI in our institution. 46 had predominant pulmonary stenosis (PS) and 13 had predominant pulmonary regurgitation (PR). They answered the quality of life questionnaire (SF-36) and underwent a cardiopulmonary exercise test and Cardiovascular Magnetic Resonance before and 6 months after PPVI. Results Peak oxygen uptake improved significantly from 27.2 (18.9; 34.0) ml/min/kg to 29.2 (22.4; 35.3) ml/min/kg (p <.0001), and from 69.6 (55.9; 83.6) %predicted to 76.3 (67.9; 92.7) %predicted, respectively. Improvements were seen in both, the PS (71.9 to 78.3 %predicted; p <.0001) and PR (62.7 to 73.0 %predicted; p <.0001) group. Self-estimated quality of life was good already before PPVI but increased in almost all domains 6 months after PPVI in PS and PR group. Significant improvements developed in "physical function", "general health perception" and "health transition" in both groups, and "physical role functioning", "vitality" and "mental health" only in the PS group. Conclusions In patients with dysfunctional pulmonary valve conduits exercise performance and quality of life improve substantially 6 months after successful percutaneous pulmonary valve implantation.
AB - Objective Percutaneous pulmonary valve implantation (PPVI) has emerged as a new approach to treat patients with dysfunctional pulmonary valve conduits. Short- and midterm results have outlined hemodynamic improvements and increase in exercise performance. However, there is a lack of knowledge about quality of life at short term follow-up. Patients and methods From July 2007 to March 2013, we investigated 59 patients (17 female; median age 22.8 years) undergoing PPVI in our institution. 46 had predominant pulmonary stenosis (PS) and 13 had predominant pulmonary regurgitation (PR). They answered the quality of life questionnaire (SF-36) and underwent a cardiopulmonary exercise test and Cardiovascular Magnetic Resonance before and 6 months after PPVI. Results Peak oxygen uptake improved significantly from 27.2 (18.9; 34.0) ml/min/kg to 29.2 (22.4; 35.3) ml/min/kg (p <.0001), and from 69.6 (55.9; 83.6) %predicted to 76.3 (67.9; 92.7) %predicted, respectively. Improvements were seen in both, the PS (71.9 to 78.3 %predicted; p <.0001) and PR (62.7 to 73.0 %predicted; p <.0001) group. Self-estimated quality of life was good already before PPVI but increased in almost all domains 6 months after PPVI in PS and PR group. Significant improvements developed in "physical function", "general health perception" and "health transition" in both groups, and "physical role functioning", "vitality" and "mental health" only in the PS group. Conclusions In patients with dysfunctional pulmonary valve conduits exercise performance and quality of life improve substantially 6 months after successful percutaneous pulmonary valve implantation.
KW - Cardiopulmonary exercise test
KW - Congenital heart disease
KW - Intervention
KW - Melody®
KW - PPVI
KW - Percutaneous pulmonary valve implantation
KW - Quality of life
KW - Sapien®
UR - http://www.scopus.com/inward/record.url?scp=84899523412&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2014.03.002
DO - 10.1016/j.ijcard.2014.03.002
M3 - Article
C2 - 24713459
AN - SCOPUS:84899523412
SN - 0167-5273
VL - 173
SP - 388
EP - 392
JO - International Journal of Cardiology
JF - International Journal of Cardiology
IS - 3
ER -